Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 20
Cleveland Clinic to Assess Heart Risk Associated with Celebrex
Merck Opposes La. AG's Motions for Expedited Consideration, Consolidation
MDL Plaintiffs Move for National Class Subject to N.J. Law
Merck Says Employee Defendants Fraudulently Joined, Opposes Remand
Judge Appoints Committees in Bextra/Celebrex MDL
Plaintiffs Challenge 'Sweeping' Motion to Dismiss Out-of-State Claims
Judge: Vioxx Plaintiff's 'Conclusory' Allegations Against Physician Sufficient
N.J. Designates Celebrex/Bextra Claims as 'Mass Torts'
